C. Ó’Moráin

885 total citations
26 papers, 717 citations indexed

About

C. Ó’Moráin is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Ó’Moráin has authored 26 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 11 papers in Gastroenterology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Ó’Moráin's work include Helicobacter pylori-related gastroenterology studies (16 papers), Eosinophilic Esophagitis (11 papers) and Gastroesophageal reflux and treatments (8 papers). C. Ó’Moráin is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (16 papers), Eosinophilic Esophagitis (11 papers) and Gastroesophageal reflux and treatments (8 papers). C. Ó’Moráin collaborates with scholars based in Ireland, United Kingdom and United States. C. Ó’Moráin's co-authors include C. T. Keane, Anan Raghunath, S. Beattie, Stephen Patchett, Edward Leen, Shaji Sebastian, A Qasim, Thomas J. Borody, David Y. Graham and W. A. De Boer and has published in prestigious journals such as Gastroenterology, Gut and Journal of Clinical Pathology.

In The Last Decade

C. Ó’Moráin

26 papers receiving 680 citations

Peers

C. Ó’Moráin

SURGE

GASTR

PRM

EPIDE

Alain Farley Canada

W D Neithercut United Kingdom

B Tillenburg Germany

David Y. Graham United States

L. Lombardo Italy

Pedro Urruzuno Spain

Ángeles Pérez‐Aísa Spain

Barbara Porowska Italy

G. D. Kerr United Kingdom

Emily Prewett United Kingdom

Alain Farley Canada

C. Ó’Moráin

690 ×1.1

SURGE

395 ×0.9

GASTR

174 ×0.8

PRM

197 ×2.4

EPIDE

68 ×1.0

Citations per year, relative to C. Ó’Moráin C. Ó’Moráin (= 1×) peers Alain Farley

Countries citing papers authored by C. Ó’Moráin

Since Specialization

Citations

This map shows the geographic impact of C. Ó’Moráin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ó’Moráin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ó’Moráin more than expected).

Fields of papers citing papers by C. Ó’Moráin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ó’Moráin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ó’Moráin. The network helps show where C. Ó’Moráin may publish in the future.

Co-authorship network of co-authors of C. Ó’Moráin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ó’Moráin. A scholar is included among the top collaborators of C. Ó’Moráin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ó’Moráin. C. Ó’Moráin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abuzakouk, Mohamed, C. Ó’Moráin, Diarmuid O’Donoghue, et al.. (2008). Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort: Table 1. Journal of Clinical Pathology. 61(11). 1200–1202. 6 indexed citations

Holmes, Kenneth R., Brian Egan, Niall Swan, & C. Ó’Moráin. (2007). Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Current Genomics. 8(6). 379–397. 15 indexed citations

OʼSullivan, Maria, et al.. (2006). Adalimumab in the Management of Crohn's Disease (CD) Patients with a Loss of Response to Infliximab. Endoscopy. 38(11). 1 indexed citations

Raghunath, Anan, et al.. (2005). Review article: the long‐term use of proton‐pump inhibitors. Alimentary Pharmacology & Therapeutics. 22(s1). 55–63. 132 indexed citations

Sebastian, Shaji, et al.. (2004). Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results. Digestive and Liver Disease. 36(3). 212–217. 54 indexed citations

Sebastian, Shaji, et al.. (2003). Appropriateness of gastric antisecretory therapy in hospital practice. Irish Journal of Medical Science (1971 -). 172(3). 115–117. 27 indexed citations

Sebastian, Shaji, et al.. (2003). Test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?. Alimentary Pharmacology & Therapeutics. 17(s2). 82–88. 6 indexed citations

Breslin, Niall, et al.. (2000). The effects of blood on rapid urease testing forHelicobacter pylori in mucosal biopsies from the gastric antrum. Irish Journal of Medical Science (1971 -). 169(1). 60–62. 7 indexed citations

OʼSullivan, Maria, Niall Breslin, I Harman, et al.. (1999). Increased mucosal mast cells - Evidence of an inflammatory response in IBS?. Gut. 44. 1 indexed citations

10.

McNamara, Deirdre, et al.. (1999). HpSA: Assessment of a new non-invasive diagnostic assay for helicobacter pylori infection in an Irish population. Irish Journal of Medical Science (1971 -). 168(2). 111–113. 17 indexed citations

11.

Ó’Moráin, C., et al.. (1998). Different management of Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease. Gut. 43(suppl 1). S14–S20. 23 indexed citations

12.

OʼSullivan, Maria, Nadim Mahmud, Dermot Kelleher, E.G. Lovett, & C. Ó’Moráin. (1998). Educational needs in patients with irritable bowel syndrome (IBS): Implications for clinical management. Gastroenterology. 114. A816–A816. 1 indexed citations

13.

OʼSullivan, Maria, et al.. (1998). Increased mucosal mast cells in irritable bowel syndrome (IBS). Gastroenterology. 114. A816–A816. 4 indexed citations

14.

Breslin, Niall, et al.. (1997). Monozygotic twins with Crohn’s disease and ulcerative colitis: a unique case report. Gut. 41(4). 557–560. 22 indexed citations

15.

Scanlon, Colleen, et al.. (1997). A validated dyspepsia symptom score.. PubMed. 29(6). 495–500. 45 indexed citations

16.

Ó’Moráin, C., et al.. (1996). Double‐blind, Multicenter, Placebo‐Controlled Evaluation Of Clarithromycin And Omeprazole For Helicobacter Pylori‐Associated Duodenal Ulcer. Helicobacter. 1(3). 130–137. 23 indexed citations

17.

Boer, W. A. De, et al.. (1996). Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens.. PubMed. 8(7). 641–3. 80 indexed citations

18.

Xia, Han, Mohamed A. Daw, S. Beattie, C. T. Keane, & C. Ó’Moráin. (1993). Prevalence of metronidazole-resistant helicobacter pylori in dyspeptic patients. Irish Journal of Medical Science (1971 -). 162(3). 91–94. 28 indexed citations

19.

Sant, S, et al.. (1993). Percutaneous endoscopic gastrostomy — its application in patients with neurological disease. Irish Journal of Medical Science (1971 -). 162(11). 450–451. 3 indexed citations

20.

Humphreys, H. & C. Ó’Moráin. (1988). Culture of the Organisms and Histochemical Identification. Scandinavian Journal of Gastroenterology. 23(sup142). 16–20. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact